Skip to content

Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia

Visceral Leishmaniasis and Malnutrition in Amhara Regional State, Ethiopia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02148822
Acronym
VL&MNEthio
Enrollment
520
Registered
2014-05-28
Start date
2009-12-31
Completion date
2011-02-28
Last updated
2014-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malnutrition, Visceral Leishmaniasis

Keywords

Visceral leishmaniasis, kala azar, malnutrition, stunting, thinness, Leishmania donovani

Brief summary

The project Visceral Leishmaniasis and Malnutrition is a cohort study that aimed to assess the association between malnutrition and visceral leishmaniasis (VL). It was conducted in Libo Kemkem and Fogera districts of the Amhara Regional State in Ethiopia. Clinical, anthropometric, biochemical, immunological, parasitological and sociodemographic data of school age children from VL high prevalence communities were collected in December 2009, May 2010 and February 2011.

Interventions

None listed

Sponsors

UBS Optimus Foundation
CollaboratorOTHER
Armauer Hansen Research Institute, Ethiopia
CollaboratorOTHER
Instituto de Salud Carlos III
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

* Reported age between 4 and 15 years of age * Currently living in the selected household

Exclusion criteria

* To be ill of visceral leishmaniasis at the time of the survey * To be positive to visceral leishmaniasis infection tests at the time of the first survey * To be under treatment for visceral leishmaniasis at the time of the survey * To be extremely ill of any other condition

Design outcomes

Primary

MeasureTime frame
visceral leishmaniasis diseaseDecember 2009, May 2010 and February 2011 (up to 14 months)

Secondary

MeasureTime frame
visceral leishmaniasis infectionDecember 2009, May 2010 and February 2011 (up to 14 months)

Other

MeasureTime frame
GrowthDecember 2009, May 2010 and February 2011 (up to 14 months)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026